BRPI0810664A2 - epítopo funcional de osteopontina, o anticorpo monoclonal anti-osteopontina e seu uso. - Google Patents

epítopo funcional de osteopontina, o anticorpo monoclonal anti-osteopontina e seu uso.

Info

Publication number
BRPI0810664A2
BRPI0810664A2 BRPI0810664A BRPI0810664A BRPI0810664A2 BR PI0810664 A2 BRPI0810664 A2 BR PI0810664A2 BR PI0810664 A BRPI0810664 A BR PI0810664A BR PI0810664 A BRPI0810664 A BR PI0810664A BR PI0810664 A2 BRPI0810664 A2 BR PI0810664A2
Authority
BR
Brazil
Prior art keywords
osteopontin
monoclonal antibody
functional epitope
epitope
functional
Prior art date
Application number
BRPI0810664A
Other languages
English (en)
Inventor
Kou Geng
Wang Hao
Dai Jianxin
Fan Kexing
Hou Sheng
Qian Weizhu
Guo Yajun
Original Assignee
Shanghai Nat Eng Res Center Of Antibody Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Nat Eng Res Center Of Antibody Medicine Co Ltd filed Critical Shanghai Nat Eng Res Center Of Antibody Medicine Co Ltd
Publication of BRPI0810664A2 publication Critical patent/BRPI0810664A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0810664A 2007-04-24 2008-03-25 epítopo funcional de osteopontina, o anticorpo monoclonal anti-osteopontina e seu uso. BRPI0810664A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2007100398786A CN101293916A (zh) 2007-04-24 2007-04-24 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及用途
PCT/CN2008/070582 WO2008128456A1 (fr) 2007-04-24 2008-03-25 Épitope fonctionnel d'ostéopontine, anticorps monoclonal anti-ostéopontine et leur utilisation

Publications (1)

Publication Number Publication Date
BRPI0810664A2 true BRPI0810664A2 (pt) 2017-06-06

Family

ID=39875089

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810664A BRPI0810664A2 (pt) 2007-04-24 2008-03-25 epítopo funcional de osteopontina, o anticorpo monoclonal anti-osteopontina e seu uso.

Country Status (7)

Country Link
US (1) US20100239588A1 (pt)
EP (1) EP2143734A4 (pt)
JP (1) JP2010524475A (pt)
CN (2) CN101293916A (pt)
BR (1) BRPI0810664A2 (pt)
CA (1) CA2685185A1 (pt)
WO (1) WO2008128456A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101891814B (zh) * 2009-05-21 2012-11-07 中国科学院上海生命科学研究院 抗骨桥蛋白opn单克隆抗体及其应用
CN102942630A (zh) * 2012-10-17 2013-02-27 杭州德同生物技术有限公司 抗骨桥蛋白抗体
CN104327166B (zh) * 2013-03-06 2018-02-23 南昌大学 赭曲霉毒素a的十二肽抗原模拟表位及其应用
IL270199B2 (en) 2017-05-04 2024-07-01 Follicum Ab Peptides for the treatment of diabetes
CN112480250B (zh) * 2020-12-23 2022-03-15 上海交通大学 一种抗人骨桥蛋白的抗体及其应用
CN113567573B (zh) * 2021-07-09 2023-06-02 黑龙江飞鹤乳业有限公司 骨桥蛋白的分离方法和分析方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPH09191886A (ja) * 1996-01-19 1997-07-29 Asahi Breweries Ltd ヒト高親和性ＩｇＥ受容体に対するヒト型化抗体、半キメラ抗体およびキメラ抗体
EP1175223A2 (en) * 1999-04-15 2002-01-30 Children's Medical Center Corporation Methods and compositions for modulating an immune response
ES2314040T3 (es) * 2001-04-05 2009-03-16 Immuno-Biological Laboratories Co., Ltd. Anticuerpo anti-osteopontina y su uso.
CN1351888A (zh) * 2001-11-10 2002-06-05 河北医科大学 抗骨桥蛋白抗体类药物生产方法及用途
EP1637159A4 (en) * 2003-05-23 2009-01-21 Immuno Biological Lab Co Ltd IMMUNOMETIMENT CELL ACTIVATION INHIBITOR AND ITS USE

Also Published As

Publication number Publication date
CN101293916A (zh) 2008-10-29
JP2010524475A (ja) 2010-07-22
EP2143734A1 (en) 2010-01-13
CN101679518A (zh) 2010-03-24
US20100239588A1 (en) 2010-09-23
CN101679518B (zh) 2012-11-14
WO2008128456A1 (fr) 2008-10-30
CA2685185A1 (en) 2008-10-30
EP2143734A4 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
LTPA2020523I1 (lt) Anti-CD79b antikūnai ir imunokonjugatai ir jų panaudojimo būdai
BRPI0816919A2 (pt) Redução de infecções concomitantes em porcos pelo uso de antígeno pcv2.
IL272883A (en) Monoclonal antibodies and their uses
NZ602294A (en) Monoclonal antibodies against c-met
BR112012003759A2 (pt) "anticorpo anti-cmet e seu uso para a detecção e o diagnóstico de câncer."
DK2019840T3 (da) Antagonist anti-human CD40 monoklonalt antistof.
EP2322562A4 (en) MONOCLONAL ANTIBODY AND IMMUNASSAY WITH IT
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
IL205127A0 (en) Humanized a?? antibody, composition comprising the same and uses thereof
BRPI0923231A2 (pt) anticorpo anti-cmet.
EP1940466A4 (en) ANTI-ADDL MONOCLONAL ANTIBODIES AND THEIR USE
DK2061814T3 (da) Antistoffer og immunokonjugater og anvendelse deraf.
SV2007002227A (es) Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637
NO344963B1 (no) Humanisert antistoff
BRPI0808655A2 (pt) anticorpos monoclonais de he4 e métodos para a sua utilização.
IS8596A (is) Mótefni gegn CD154
BRPI0817250A2 (pt) Anticorpo anti-receptor da il-6.
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0912285A2 (pt) anticorpos monoclonais tendo propriedades de neutralização cruzada de homosubtipo contra o vírus influenza subtipo h1.
WO2015010100A3 (en) Humanized antibodies with ultralong complementarity determining regions
BRPI0817273A2 (pt) Região constante de anticorpo modificada
DK1964852T3 (da) Anti-ilt7-antistof
NO20076607L (no) TWEAK - bindende antistoff
DK2292663T3 (da) Antagonistiske human-let-specifikke, humane monoklonale antistoffer
EP2195023A4 (en) HUMANIZED ANTI-CXCR5 ANTIBODIES, DERIVATIVES THEREOF AND USES THEREOF

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]